Do GLP-1 patches work? What they contain and what research shows

If you have searched for "GLP-1 patches," you have probably seen a lot of confident claims and not many straight answers. Here is the short version. There is no FDA approved GLP-1 patch. The products sold under that name are marketed as dietary supplements, and a 2026 review of these products found they list botanical and nutrient ingredients rather than any GLP-1 receptor agonist medication.

That is a different category from prescription GLP-1 care. Tirzepatide is FDA approved as Zepbound and semaglutide as Wegovy, and both are also prescribed in compounded form by licensed providers. Compounded medications are not FDA approved finished products. A licensed provider determines eligibility. This page walks through what the patches contain, what the research does and doesn't show, and how to evaluate a GLP-1 claim when you see one.

What is actually in a GLP-1 patch?

Researchers at the University of Connecticut School of Pharmacy looked at this directly. In a 2026 paper in the Annals of Pharmacotherapy, they identified 24 transdermal patch dietary supplement products and 1 transdermal gel product. The products listed an average of 7 ± 4 natural ingredients, with berberine, glutamine or glutamate, cinnamon and pomegranate listed most often.

None of those is a GLP-1 receptor agonist. The "GLP-1" on the label describes what the product is positioned to support, not a medication it contains. That is worth knowing before anything else, because it changes the question. You are not comparing two ways of taking the same medicine. You are comparing a supplement blend to a prescription drug.

The same researchers reported that no certificates of analysis were posted for the products, that many lacked the FDA disclaimer required on supplement labels, and that many used deceptive advertising. Those findings are about how these products are sold. They are not a judgment on anyone who has been curious about them.

Is a GLP-1 patch the same as GLP-1 medication?

No, and the reason is partly chemistry. Tirzepatide and semaglutide are peptides, chains of amino acids, and they are large molecules. The Zepbound prescribing information lists the molecular weight of tirzepatide as 4813.53 Da. The Wegovy prescribing information lists the molecular weight of semaglutide as 4113.58 g/mol.

Skin is built to keep molecules out. In a widely cited paper in Experimental Dermatology, dermatologists argued that a compound's molecular weight must be under 500 Dalton to allow skin absorption, and that larger molecules cannot pass the outer corneal layer. They noted that all known topical drugs used in transdermal drug-delivery systems at the time were under 500 Dalton. By that standard, a GLP-1 medication is many times too large to move through intact skin from a simple patch.

That is why the FDA approved forms of these medications are not patches. Zepbound is an injection under the skin. The Wegovy listing on DailyMed covers both an injection and a tablet. How a medication reaches the body is part of what FDA reviews when it approves a drug. Format is not a detail here. It is part of the medicine.

What does the research show about the ingredients?

Berberine is the ingredient that comes up most, so it is the fairest place to look. According to the National Center for Complementary and Integrative Health (NCCIH), berberine is a substance found in plants including goldenseal, barberry and Oregon grape. It is being studied for its effects on diabetes and heart disease risk factors, and it has become popular as a potential weight loss aid.

Here is the map of what is known. NCCIH describes a 2022 review of 18 studies on body weight and 23 on BMI that found significant decreases in people who took berberine. NCCIH also notes that many of those studies had a high risk of bias, results were inconsistent, formulations varied widely, and most participants had conditions such as diabetes or fatty liver disease. Its summary is that some studies suggest berberine might help, and the evidence is not conclusive.

Two things are worth holding at once. Berberine is a real compound that researchers are actively studying. And none of that research, as NCCIH summarizes it, tells you whether a patch on your skin delivers a meaningful amount of it. A 2026 review in Pharmaceuticals reported that berberine has very low systemic exposure even when taken by mouth. Delivery through skin is a separate question the ingredient studies do not answer.

The honest summary: the patch format has no published trial record showing weight outcomes that we could find, and the leading ingredient has early, mixed evidence in its oral form. That is a status, not a verdict on anyone's choices.

"When a patient tells me they tried a GLP-1 patch, I start by asking what they were hoping it would do, because that goal is usually a real and reasonable one. I prescribe tirzepatide and semaglutide after a full medical intake, and I stay involved: we monitor how it's going and adjust as treatment progresses. Medication is one part of the plan, never the whole plan. Eating, movement, sleep and follow up do a lot of the work."

Are GLP-1 patches legal and regulated?

GLP-1 patches are marketed as dietary supplements, which follow different rules from drugs. FDA states that under the Dietary Supplement Health and Education Act (DSHEA), it does not have the authority to approve dietary supplements before they are marketed. Supplement labels must carry a disclaimer that the product is not intended to "diagnose, treat, cure, or prevent any disease," because only a drug can legally make such a claim.

The Annals of Pharmacotherapy authors went further. They wrote that DSHEA specifies dietary supplement products must be swallowed, so in their analysis, transdermal supplement patches are illegal as a category. That is their legal reading, published in a peer reviewed journal, and it is one more reason a patch and a prescription sit in entirely different places.

Prescription GLP-1 medications follow the drug pathway. Brand tirzepatide and semaglutide went through FDA review for their labeled uses. Compounded versions are prepared by licensed compounding pharmacies for an individual patient under a prescription. Belle's important safety information states that compounded medications are not evaluated by FDA for safety or effectiveness. Being prescription and provider reviewed is not the same as being FDA approved, and Belle does not claim otherwise.

Are GLP-1 patches safe?

There is not much published safety data on the patch products themselves. What is known comes from the ingredients. NCCIH reports that side effects of berberine in research studies have been primarily gastrointestinal: nausea, abdominal pain, bloating, constipation or diarrhea. It also notes that berberine may interact with medicines, including cyclosporine, a transplant medication.

The 2026 Pharmaceuticals review adds that berberine should be managed as an active pharmacological substance rather than an inert supplement, particularly alongside other medications. That is the practical point: a "natural" label does not mean a product has no effects, and anything that can change how your other medications work belongs on your medication list.

Who should talk to a provider first

• Pregnancy or breastfeeding (NCCIH notes berberine may be unsafe during pregnancy or while breastfeeding)
• Taking prescription medications, especially transplant, blood sugar or blood pressure medications
• Diabetes or any condition treated with glucose-lowering medication
• Liver or kidney conditions
• Already taking, or considering, a prescription GLP-1 medication

How to evaluate a GLP-1 claim

You don't need a pharmacology degree to sort these products. A few questions do most of the work.

• Does it contain a GLP-1 receptor agonist? Read the ingredient list. If you don't see tirzepatide or semaglutide, the product is not GLP-1 medication.
• Is it a drug or a supplement? A product with the supplement disclaimer is telling you it is not intended to treat any disease.
• Is there a prescriber involved? GLP-1 medications require a prescription from a licensed provider after a review of your health history.
• Is there evidence for this exact product and format? Research on an ingredient taken by mouth is not evidence for a patch.
• Does the claim promise a number? Real clinical language is measured because outcomes vary by individual. When a claim sounds like an advertisement, treat that as a reason to slow down.

What prescription GLP-1 care looks like instead

If what drew you to a patch was wanting help with appetite and weight, that is a medical goal, and it deserves a medical answer. Belle offers compounded tirzepatide and compounded semaglutide. It starts with an online intake reviewed by a licensed provider, who decides whether a prescription is appropriate. If it is, the medication is prepared by a licensed compounding pharmacy and delivered to your door. A prescription is never guaranteed. If a treatment is not appropriate for you, the answer is no, and that is the point of the review.

If you are weighing the two medications, our guide to tirzepatide vs semaglutide covers how they differ, and GLP-1 without insurance walks through paying for treatment on your own.

Expectations matter too. Many patients report changes in appetite early in treatment. Weight change is typically gradual, and the Zepbound trials measured weight reduction after 72 weeks, which is a long runway compared with how most people judge a product after a month. Timelines and outcomes vary by individual, and your provider will monitor your progress and adjust your plan as needed.

Nothing here is medical advice. Decisions about your own care belong with a licensed provider who knows your history.

Key points

• There is no FDA approved GLP-1 patch. Products sold as "GLP-1 patches" are marketed as dietary supplements, and FDA does not approve dietary supplements before they are marketed.
• A 2026 review of 24 patch products found botanical and nutrient ingredients such as berberine, glutamine, cinnamon and pomegranate, not a GLP-1 receptor agonist medication.
• Tirzepatide and semaglutide are large peptide molecules, far above the size researchers describe as the practical limit for passing through skin.
• Research on berberine itself is early and mixed, and it says nothing about whether a patch delivers it.
• If a patch caught your eye because you want help with weight, that goal is worth a real conversation with a licensed provider.

Q: Are GLP-1 patches FDA approved?

A: No. There is no FDA approved GLP-1 patch. Products sold under that name are marketed as dietary supplements, and FDA states it does not have the authority to approve dietary supplements before they are marketed. The FDA approved forms of tirzepatide and semaglutide are prescription medications, not patches.

Q: Does Belle offer GLP-1 patches?

A: No. Belle offers compounded tirzepatide and compounded semaglutide as prescription medications, available after an online intake and review by a licensed provider. Neither compounded medication is an FDA approved finished product, and a prescription is never guaranteed.

Q: Do GLP-1 patches contain GLP-1 medication?

A: Not the products researchers have reviewed. A 2026 Annals of Pharmacotherapy analysis of 24 patch products and 1 gel found natural ingredients such as berberine, glutamine or glutamate, cinnamon and pomegranate, not a GLP-1 receptor agonist.

Q: Can tirzepatide or semaglutide be absorbed through the skin?

A: Not from a simple patch, based on current understanding. Tirzepatide's listed molecular weight is 4813.53 Da and semaglutide's is 4113.58 g/mol. Dermatology researchers have argued that compounds generally need a molecular weight under 500 Dalton to pass through skin.

Q: Does berberine work like a GLP-1 medication?

A: Berberine is a plant compound being studied for metabolic effects. NCCIH says some studies suggest it might help with weight and the evidence is not conclusive. It is not a GLP-1 receptor agonist medication, and research on it taken by mouth does not show what a patch delivers.

Q: Can I use a GLP-1 patch while taking prescription GLP-1 medication?

A: Tell your provider about any supplement before combining it with a prescription. NCCIH notes berberine may interact with medicines, and a 2026 review advises treating it as an active substance rather than an inert supplement.